Our core team of Agile Advisors is comprised of seasoned executives specializing in biotech and life sciences, with a strong focus on business development, corporate strategy and data analytics. The core team is instrumental not only in executing assigned projects but also in managing the engagement of our extended team of Agile Advisors, ensuring seamless operations and delivery of customized solutions.
Seasoned Life Science professional and licensed Business Advisor focused on the Pharma, Biotech and Medtech sectors. Background in R&D, business development, and operations management. Pioneered biosimilars, vaccines, gene therapies, and orphan drugs. Skilled in selling and acquiring highly complex technologies and products, including those relevant for the CDMO industry. Adept at attracting new customers, in- and out-licensing, due diligences, and investing. Technical proficiency spans manufacturing, supply chain, quality systems, and process qualification. Managed large capital investment programs ranging from planning to new site commissioning. PhD in Chemical Sciences from the Technical University of Vienna.
Currently pursuing a Bachelor’s degree in Business Law (LL.B.) at the Vienna University of Economics and Business, Tobias is a driven professional with diverse experience across legal research, digital project management, and financial analysis. As a co-founder and former Vice President of the FUA Investment Club, he has played a pivotal role in shaping market strategies and delivering comprehensive financial insights. Certified as a Financial Modeling & Valuation Analyst (FMVA), he brings a strong analytical background, having worked on M&A modeling, market analysis, and contract development for Agile projects. Tobias has a proven track record of contributing to high-impact projects, including delivering investment proposals to senior management and collaborating with financial institutions. His hands-on experience across various sectors reflects his capability in navigating complex business environments and driving value through strategic initiatives.
BSc, MBA. Experienced healthcare professional with a focus on biotech, medical devices, medical technologies, and life sciences. Global reach spanning the USA, Europe, and Asia with in-depth experiences in business development, corporate strategy and advisory, compliance consulting, and scientific R&D for multinational pharmaceutical corporations, major investment banks, consulting firms, and early-stage companies. MBA from the University of Cambridge, UK, with a specialization in Finance, complemented by a BSc in Biochemistry from Seattle University, USA.
MBBS (Lond), PhD, MBA, MRCS (Eng), FRCS (GenSurg), FEBS (GenSurg), FACS, CMgr FCMI FFTACC FISS, AKC
Senior medical advisor and retired Surgeon Commander, Royal Navy, with a robust background in trauma surgery and emergency management across military and civilian sectors. Experienced in executive roles, MedTech, Pharma, including advising national trauma systems and directorships in private healthcare organizations in the UK and internationally. Actively contributes to academic and clinical advancements as a Visiting Professor in Security Sciences and General Surgery across multiple international institutions. Holds an MBA from the University of Northampton and a PhD from the University of Warwick.
PhD, MBA. Senior executive with global leadership roles at multinational pharmaceutical companies. Extremely well connected within the private equity landscape with first-hand experience supporting M&A operations for companies in Hungary, Croatia, Russia, and Spain. Led large, innovative teams in R&D and Scientific Affairs. Highly experienced within the CRO and CDMO landscape. MSc in Engineering and PhD in Chemical Sciences from the University of Ljubljana. MBA from IEDC – Bled School of Management.
Former Vice President in Investment Banking with a specialized focus on Healthcare, Medical Technology, and Diagnostics. Extensive expertise in originating and executing strategic and financial transactions across both private and public markets. Successfully conducted over 20 due diligence processes, including transactions with values ranging from $50 million to $4 billion. Earned his Bachelor of Science (B.S.) in Management, with a concentration in Finance, from Boston College in 2019. Bryan became one of the youngest professionals to achieve the prestigious Vice President designation in the industry.
Innovation accelerator and market access executive. Worked as partner at a consulting firm specialized on vaccine products, the worldwide vaccine market, and virtually every vaccine indication. Strong people manager, negotiator and communicator with extensive Marketing & Sales experience. Deep knowledge in vaccines, haemophilia, rare diseases, oncology, immunology, genetic diseases and women’s health. Bernd was responsible for a wide range of global pricing and market access initiatives for vaccines. His solutions range from vaccine development and strategic market access considerations for trial designs to value demonstrations in P&R negotiations as well as commercialization strategies. Diploma in Economics, International Marketing and HR.
Innovation accelerator specialized in the field of Advanced Therapies. Track record for execution of large programs from Development, Tech Transfers , GMP manufacturing, Clinical Supply and Commercialization of Cell and Gene Therapies. Successful management of +20 Tech Transfers in non GMP to GMP environment, across modalities, from US to Europe and within Europe. Special focus on hands on professional project management, lean principles, process digitalization and automation. Senior level experience in executive roles in Pharma, Biotech, CDMOs, NGOs and academia. Diploma in Human Nutrition, PhD in Neuropharmacology from University of Potsdam, Germany.